Tabakman, R. (Contributor), Cendrowicz, E. (Contributor), Pecker, I. (Contributor), Gozlan, Y. (Contributor), Kahn, R. (Contributor), Dranitzki, M. E. (Contributor), Tamir, A. (Contributor), Tamir, L. (Contributor), Jacob, L. (Contributor), van Meerten, T. (Contributor), Avichzer, J. (Contributor), Peled, A. (Contributor), Aronin, A. (Contributor), Amsili, S. (Contributor), Vlaming, M. (Contributor), Huls, G. (Contributor), Foley-Comer, A. (Contributor), Chajut, A. (Contributor), Zorde-Khvalevsky, E. (Contributor), Pereg, Y. (Contributor), Greenwald, S. (Contributor), Ghantous, L. (Contributor), Bremer, E. (Contributor) (
15-Mar-2022). Additional file 1 of DSP107 combines inhibition of CD47/SIRPα axis with activation of 4-1BB to trigger anticancer immunity. figshare Academic Research System.
10.6084/m9.figshare.19359964.v1